Rotigotine (Transdermal Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Rotigotine (Transdermal Route)

Drug Information provided by: Micromedex

US Brand Names

  • Neupro

Description

Rotigotine is used to treat the symptoms of Parkinson's disease, sometimes called shaking palsy. It is a dopamine agonist that helps improve muscle control and reduce muscle stiffness to allow more normal movements of the body.

This medicine was available only with your doctor's prescription.

Transdermal products containing rotigotine (Neupro®) were withdrawn from the U.S. market by Schwarz Pharma on April 30, 2008.

Before Using
DR602471 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger